Skip to content

Cancer of the Upper Aero-digestive Tract and Socio-professional Future

Cancer of the Upper Aero-digestive Tract and Socio-professional Future

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01788878
Acronym
CARDEL
Enrollment
46
Registered
2013-02-11
Start date
2014-02-28
Completion date
2018-05-31
Last updated
2016-07-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Upper Aerodigestive Tract Neoplasms

Keywords

socio-professional future

Brief summary

The aim of this study is to explore the main factors associated with the return to work of patients presenting an upper aero-digestive tract cancer.

Detailed description

Socio-professional, medical, psychological, demographic, economic, and educational data collection in patients within the care pathway of upper aero-digestive tract cancer. A series of questionnaires will be presented at the initial consultation and then at 6 months, at 12 months and at 18 months during follow-up visits. Medical data will be collected via the CRF.

Interventions

BEHAVIORALQuestionnaires

A first series of questionnaires will be given by the investigator at patients before treatment (inclusion visit) and then the questionnaires will be given at the follow-up visits planned at 6 months, 12 months and 18 months. Medical data will be collected via the CRF.

Sponsors

University Lille 3
CollaboratorUNKNOWN
Région Nord-Pas de Calais, France
CollaboratorOTHER
University Hospital, Lille
CollaboratorOTHER
Centre Oscar Lambret
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

* Age at diagnosis ≥ 18 to ≤ 55 years * Employed at the entry into the care pathway * Presenting an upper aero-digestive tract cancer (excluding nasal cavities), stage I, II and III, under a first anti-tumor treatment (surgery, radiotherapy, or chemotherapy) * Patient mastering the French language * Affiliated to the social security system * Consent signed by the patient before the implementation of any specific study procedure

Exclusion criteria

* Having been treated for another cancer before (except skin cancer and / or prostate) * Metastatic disease from the outset * Patient unable to submit to a regular follow-up * Presenting psychiatric disorders

Design outcomes

Primary

MeasureTime frame
Main psycho-medical and socio-professional determinants associated with return to work at 18 months after diagnosisAt month 18

Secondary

MeasureTime frame
Period until return to work (also part-time work)At month 6, month 12, month 18
Modalities, period and stability of this return to workAt month 6, month 12, month 18
Alternatives to return to work (retirement, disability, etc ...)At month 6, month 12, month 18
Psychological factors that might interfere with the behaviors to return to workAt baseline, Month 6, Month 12, Month 18
Information collected in the perceived support part of the questionnaireAt baseline, Month 6, Month 12, Month 18

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026